Acquisition by Mahal Jeetinder Singh of 900 shares of Jasper Therapeutics at 7.1 subject to Rule 16b-3
| JSPR Stock | USD 20.87 1.60 8.30% |
Slightly above 55% of Jasper Therapeutics' retail investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Jasper Therapeutics suggests that some traders are interested. Jasper Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Jasper Therapeutics. Many technical investors use Jasper Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Jasper |
Filed transaction by Jasper Therapeutics Officer: Chief Operating Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Jasper Therapeutics Fundamental Analysis
We analyze Jasper Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jasper Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jasper Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Jasper Therapeutics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Jasper Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jasper Therapeutics stock to make a market-neutral strategy. Peer analysis of Jasper Therapeutics could also be used in its relative valuation, which is a method of valuing Jasper Therapeutics by comparing valuation metrics with similar companies.
Peers
Jasper Therapeutics Related Equities
| LYRA | Lyra Therapeutics | 4.76 | ||||
| EPIX | ESSA Pharma | 3.23 | ||||
| INBX | Inhibrx | 2.29 | ||||
| HOOK | Hookipa Pharma | 1.08 | ||||
| EQ | Equillium | 1.28 | ||||
| IKNA | Ikena Oncology | 1.78 | ||||
| ABOS | Acumen Pharmaceuticals | 2.63 | ||||
| ORIC | Oric Pharmaceuticals | 2.69 | ||||
| ELDN | Eledon Pharmaceuticals | 3.93 | ||||
| EWTX | Edgewise Therapeutics | 4.18 | ||||
| DSGN | Design Therapeutics | 5.26 | ||||
| INZY | Inozyme Pharma | 5.86 | ||||
| XLO | Xilio Development | 8.18 |
Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.